CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

As reported by Business News

CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Business News ↗

Market Samachar is a news aggregator. This article was originally published by Business News. Tap the button above to read the full story on their site.

INDIAN Pharma stock declares 18% final dividend along with Q4 results 2026 mint - markets
INDIAN Gold rate today: MCX gold prices tank over ₹2,000 to below ₹1,54000 as fresh US-Iran tensions raise inflation woes mint - markets
INDIAN US stock market today: Dow Jones, Nasdaq slip as Middle East tensions intensify; Brent crude rebounds mint - markets
INDIAN US Stock Market Today Live Updates: US stocks edge marginally lower; traders assess inflation data, Mideast developments mint - markets
INDIAN US stocks today: US stocks hold near records even as crude oil prices rise again Markets-Economic Times
INDIAN US jobless claims rise to 215,000 but layoffs remain low despite Iran war uncertainty Markets-Economic Times
INDIAN Quote of the day by Robert Wilson: "The only way one makes money in the market is when the market’s perception of a stock changes" Markets-Economic Times
INDIAN Power stocks surge on strong order books, demand outlook and earnings Markets

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

More from Market Samachar